Azafaros is a clinical-stage company developing innovative therapies for rare lysosomal storage disorders, including Niemann-Pick disease Type C and GM1/GM2 gangliosidoses.

Avidicure is a biotechnology company developing innovative multifunctional antibodies for oncology, focusing on non-small cell lung cancer.

RhyGaze is a biotechnology company developing gene therapies for vision restoration in retinal diseases.

Citryll is a biotech company developing therapies for immune-mediated inflammatory diseases, focusing on a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).

Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates for cancer treatment.

VectorY Therapeutics is a biotech company focused on developing vectorized antibody therapies for neurodegenerative diseases, with a lead program targeting Amyotrophic Lateral Sclerosis (ALS).

Tessellate BIO is a preclinical stage biotechnology company that develops precision oncology medicines targeting the DNA damage response and cancers relying on Alternative Lengthening of Telomeres (ALT).